QRCC Seminar Series 2015 Seminar #2: The changing face of clinical drug development in Europe


18-05-2015

QRC Consultants Ltd will be holding an informative and interactive seminar to learn more about clinical trial processes in the EU & financial incentives when including Europe in your development Program.

 

Join QRC Consultants for their second seminar in the 2015 series:  "The Changing Face of Clinical Drug Development in Europe" on Tuesday 23 June 2015.

Speakers include:

  • Sarah Fryer, Director QRCC
  • Dr Sarah Nicholson, Principal Regulatory Consultant QRCC
  • Rob Johnson, Partner, Alacrita
  • Dr William (Bill) Slichenmyer, Partner, Alacrita.

Topics to be covered include:

  • Changing regulatory environment
  • Financial incentives on offer in the EU
  • Advantages for clinical development in the EU

Date : Tuesday 23 June 2015  9:00am

Venue:  British Consulate, One Broadway, 7th Floor, Cambridge Massachusetts, USA

Cost:  FREE

To book your place please contact enquiries@qrcc.co.uk

 

 

About QRC Consultants Ltd

QRC Consultants Ltd is a team of experienced QA, regulatory and clinical research professionals, dedicated to providing high quality, practical, responsive and cost effective services to support biotechnology and pharmaceutical companies primarily with early stage clinical development.

For further information, please see www.qrcc.co.uk or email enquiries@qrcc.co.uk

_____________________________________

 

 

QRC Consultants is an expert consultancy supporting regulatory compliance for biotechnology and pharmaceutical companies in clinical drug development in UK, EU and globally.

QRC Consultants Ltd